Update shared on15 Jul 2025
Fair value Increased 10%Despite lower consensus revenue growth forecasts, MedPlus Health Services’ sharply improved net profit margin has driven a notable increase in the consensus analyst price target from ₹965.39 to ₹1064.
Valuation Changes
Summary of Valuation Changes for MedPlus Health Services
- The Consensus Analyst Price Target has significantly risen from ₹965.39 to ₹1064.
- The Consensus Revenue Growth forecasts for MedPlus Health Services has significantly fallen from 16.3% per annum to 12.7% per annum.
- The Net Profit Margin for MedPlus Health Services has significantly risen from 3.60% to 4.12%.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.